Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways
Berberine (BBR) is a promising anti-diabetic isoquinoline alkaloid from Rhizoma coptidis, while its bioavailability was extremely low. Here, the existing form and pharmacokinetics of BBR were comparatively characterized in conventional and antibiotic-induced pseudo germ-free (PGF) rats. Furthermore,...
Main Authors: | Yaoxing Dou, Ronglei Huang, Qiaoping Li, Yuhong Liu, Yucui Li, Hanbin Chen, Gaoxiang Ai, Jianhui Xie, Huifang Zeng, Jiannan Chen, Chaodan Luo, Ziren Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221000974 |
Similar Items
-
Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins
by: Haoyue Zhang, et al.
Published: (2018-12-01) -
A safer hypoglycemic agent for type 2 diabetes—Berberine organic acid salt
by: Jing-wan Li, et al.
Published: (2017-11-01) -
Structural modification of berberine alkaloid and their hypoglycemic activity
by: Yangping Ding, et al.
Published: (2014-03-01) -
MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability
by: Aiting Wang, et al.
Published: (2020-07-01) -
Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect
by: Yin J, et al.
Published: (2017-12-01)